| 000 | 02380 a2200649 4500 | ||
|---|---|---|---|
| 005 | 20250513201927.0 | ||
| 264 | 0 | _c20000224 | |
| 008 | 200002s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPerkins, C | |
| 245 | 0 | 0 |
_aArsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or Bcl-x(L). _h[electronic resource] |
| 260 |
_bBlood _cFeb 2000 |
||
| 300 |
_a1014-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xbiosynthesis |
| 650 | 0 | 4 |
_aATP-Binding Cassette Transporters _xbiosynthesis |
| 650 | 0 | 4 |
_aAcetylation _xdrug effects |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aApoptotic Protease-Activating Factor 1 |
| 650 | 0 | 4 | _aArsenic Trioxide |
| 650 | 0 | 4 |
_aArsenicals _xpharmacology |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 |
_aCytochrome c Group _xmetabolism |
| 650 | 0 | 4 |
_aCytosol _xmetabolism |
| 650 | 0 | 4 | _aDrug Resistance, Multiple |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aFas Ligand Protein |
| 650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xbiosynthesis |
| 650 | 0 | 4 | _aGene Expression Regulation, Leukemic |
| 650 | 0 | 4 | _aGenes, bcl-2 |
| 650 | 0 | 4 |
_aHL-60 Cells _xdrug effects |
| 650 | 0 | 4 |
_aHistones _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunophenotyping |
| 650 | 0 | 4 |
_aK562 Cells _xdrug effects |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xgenetics |
| 650 | 0 | 4 |
_aMacrophage-1 Antigen _xbiosynthesis |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xbiosynthesis |
| 650 | 0 | 4 |
_aMitochondria _xmetabolism |
| 650 | 0 | 4 | _aMultidrug Resistance-Associated Proteins |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xbiosynthesis |
| 650 | 0 | 4 |
_aOxides _xpharmacology |
| 650 | 0 | 4 | _aProtein Biosynthesis |
| 650 | 0 | 4 |
_aProtein Processing, Post-Translational _xdrug effects |
| 650 | 0 | 4 |
_aProteins _xgenetics |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xbiosynthesis |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xbiosynthesis |
| 650 | 0 | 4 | _abcl-2-Associated X Protein |
| 650 | 0 | 4 | _abcl-X Protein |
| 650 | 0 | 4 |
_afas Receptor _xbiosynthesis |
| 700 | 1 | _aKim, C N | |
| 700 | 1 | _aFang, G | |
| 700 | 1 | _aBhalla, K N | |
| 773 | 0 |
_tBlood _gvol. 95 _gno. 3 _gp. 1014-22 |
|
| 999 |
_c10603634 _d10603634 |
||